APT Medical Inc. APT Medical Inc.

APT Medical Inc.

688617

Classificação em ações #3231
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Preço da ação
$38.62
Valor de mercado
$5.47B
Variação (1 dia)
0.19%
Variação (1 ano)
-17.07%
País
CN
Negociar APT Medical Inc. (688617)

Categoria

Healthcare
Receita da APT Medical Inc. (688617)
Receita em Jun 2026 TTM: $433.73M
De acordo com os últimos relatórios financeiros da APT Medical Inc., a receita atual da empresa (TTM) é $433.73M. Em 2024, a empresa obteve uma receita de $283.02M um aumento em relação a a receita do ano 2023, que foi de $233.13M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da APT Medical Inc. de 2017 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $433.73M 17.44%
2025 $369.32M 30.49%
2024 $283.02M 21.40%
2023 $233.13M 32.24%
2022 $176.29M 35.21%
2021 $130.38M 77.65%
2020 $73.39M 26.51%
2019 $58.01M 65.05%
2018 $35.15M 49.30%
2017 $23.54M 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$48.23B 11,019.58%
US
$37.54B 8,555.60%
IE
$25.84B 5,856.92%
US
$21.00B 4,740.79%
US
$26.02B 5,898.66%
DE